Cargando…

Baseline Tumor Lipiodol Uptake after Transarterial Chemoembolization for Hepatocellular Carcinoma: Identification of a Threshold Value Predicting Tumor Recurrence

BACKGROUND: The aim of the study was to evaluate the association between baseline Lipiodol uptake in hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE) with early tumor recurrence, and to identify a threshold baseline uptake value predicting tumor response. PATIENTS AND METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsui, Yusuke, Horikawa, Masahiro, Jahangiri Noudeh, Younes, Kaufman, John A., Kolbeck, Kenneth J., Farsad, Khashayar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter Open 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765315/ https://www.ncbi.nlm.nih.gov/pubmed/29333117 http://dx.doi.org/10.1515/raon-2017-0030

Ejemplares similares

Theranostic application of lipiodol for transarterial chemoembolization in a VX2 rabbit liver tumor model
por: van Breugel, Johanna Maria Mijntje, et al.
Publicado: (2019)

Cerebral Lipiodol Embolism in Hepatocellular Carcinoma Patients Treated with Transarterial Embolization/Chemoembolization
por: Chu, Hai-Jui, et al.
Publicado: (2015)

Evaluation of novel formulations for transarterial chemoembolization: combining elements of Lipiodol emulsions with Drug-eluting Beads
por: Caine, Marcus, et al.
Publicado: (2019)

Lipiodol as an Imaging Biomarker of Tumor Response After Conventional Transarterial Chemoembolization: Prospective Clinical Validation in Patients with Primary and Secondary Liver Cancer
por: Miszczuk, Milena A., et al.
Publicado: (2020)

Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization
por: Chen, Cheng-Shi, et al.
Publicado: (2016)

Comparison of Drug Release and Pharmacokinetics after Transarterial Chemoembolization Using Diverse Lipiodol Emulsions and Drug-Eluting Beads
por: Choi, Jin Woo, et al.
Publicado: (2014)

Transarterial chemoembolization (TACE) using mitomycin and lipiodol with or without degradable starch microspheres for hepatocellular carcinoma: comparative study
por: Gruber-Rouh, Tatjana, et al.
Publicado: (2018)

Automated feature quantification of Lipiodol as imaging biomarker to predict therapeutic efficacy of conventional transarterial chemoembolization of liver cancer
por: Stark, Sophie, et al.
Publicado: (2020)

Intraarterial contrast-enhanced ultrasound to predict the short-term tumour response of hepatocellular carcinoma to Transarterial chemoembolization with Lipiodol
por: Bo, Jiang, et al.
Publicado: (2021)

Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma
por: Furumaya, Alicia, et al.
Publicado: (2019)

Sorafenib improves lipiodol deposition in transarterial chemoembolization of Chinese patients with hepatocellular carcinoma: a long-term, retrospective study
por: Zheng, Lin, et al.
Publicado: (2017)

Transarterial Chemoembolization Using Gelatin Sponges or Microspheres Plus Lipiodol-Doxorubicin versus Doxorubicin-Loaded Beads for the Treatment of Hepatocellular Carcinoma
por: Liu, Yi-Sheng, et al.
Publicado: (2015)

Angio-Computed Tomograph-Guided Immediate Lipiodol Computed Tomograph for Diagnosis of Small Hepatocellular Carcinoma Lesions during Transarterial Chemoembolization
por: Liu, Feng-Yong, et al.
Publicado: (2018)

Drug-Eluting Beads versus Lipiodol Transarterial Chemoembolization for the Treatment of Hypovascular Hepatocellular Carcinoma: A Single-Center Retrospective Study
por: Shi, Qin, et al.
Publicado: (2020)

Evaluation of Transarterial Chemoembolization Protocol with Drug-Eluting Beads in Combination with Lipiodol for Hepatocellular Carcinoma: A Single-Center Controlled Study
por: Dong, Xiangjun, et al.
Publicado: (2022)

Degradable Starch Microspheres Transarterial Chemoembolization with or without Lipiodol for Liver Metastases from Pancreatic Cancer: A Prospective Randomized Trial
por: Vogl, Thomas J., et al.
Publicado: (2023)

Local Efficacy and Safety of Transarterial Chemoembolization for Hepatocellular Carcinoma: Epirubicin-Loaded DC Beads vs. Epirubicin-Lipiodol Emulsion with Gelatin Sponge (cTACE)
por: Ono, Yusuke, et al.
Publicado: (2021)

Pulmonary lipiodol embolism following transcatheter arterial chemoembolization
por: Moriya, Tomohiro, et al.
Publicado: (2020)

Ultrasonic Heating Detects Lipiodol Deposition within Liver Tumors after Transarterial Embolization: An In Vivo Approach
por: Saito, Natsuhiko, et al.
Publicado: (2021)

Inflammatory myofibroblastic tumor mimicking hepatocellular carcinoma with dense lipiodol uptake
por: Hong, Seong Woo, et al.
Publicado: (2013)

Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response
por: Hu, Jungang, et al.
Publicado: (2016)

Evaluation of two different transarterial chemoembolization protocols using Lipiodol and degradable starch microspheres in therapy of hepatocellular carcinoma: a prospective trial
por: Vogl, T. J., et al.
Publicado: (2021)

A Nomogram Based on Preoperative Lipiodol Deposition after Sequential Retreatment with Transarterial Chemoembolization to Predict Prognoses for Intermediate-Stage Hepatocellular Carcinoma
por: Niu, Xiang-Ke, et al.
Publicado: (2022)

Lipiodol Pneumonitis Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
por: Kim, Sungkeun, et al.
Publicado: (2020)

Transarterial Ethanol Ablation Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
por: Yang, Biao, et al.
Publicado: (2016)

Transarterial Chemoembolization of Child-A hepatocellular carcinoma: Drug-eluting bead TACE (DEB TACE) vs. TACE with Cisplatin/Lipiodol (cTACE)
por: Wiggermann, Philipp, et al.
Publicado: (2011)

CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study
por: Wu, Baolin, et al.
Publicado: (2018)

Comparison of pharmacokinetics and drug release in tissues after transarterial chemoembolization with doxorubicin using diverse lipiodol emulsions and CalliSpheres Beads in rabbit livers
por: Zhang, Shuisheng, et al.
Publicado: (2017)

Initial Transarterial Chemoembolization (TACE) Using HepaSpheres 20–40 µm and Subsequent Lipiodol TACE in Patients with Hepatocellular Carcinoma > 5 cm
por: Cho, Su Min, et al.
Publicado: (2021)

Repeated transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres vs. conventional transarterial chemoembolization for hepatocellular carcinoma
por: Fukushima, Taito, et al.
Publicado: (2021)

A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
por: Sun, Tao, et al.
Publicado: (2022)

Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis
por: Lv, Wei-Fu, et al.
Publicado: (2018)

Pulmonary lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Lin, Ming-Tzer, et al.
Publicado: (2010)

Local tumor progression following lipiodol-based targeted chemoembolization of hepatocellular carcinoma: a retrospective comparison of miriplatin and epirubicin
por: Iwazawa, Jin, et al.
Publicado: (2012)

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
por: Kloeckner, Roman, et al.
Publicado: (2015)

Safety and Feasibility of Transarterial Bleomycin–Lipiodol Embolization in Patients with Giant Hepatic Hemangiomas
por: Kacała, Arkadiusz, et al.
Publicado: (2023)

Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus
por: Zheng, Ninggang, et al.
Publicado: (2016)

Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus
por: Chen, Junwei, et al.
Publicado: (2023)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
por: Baur, Johannes, et al.
Publicado: (2016)

Contrast-Enhanced Ultrasound in Residual Tumor of Hepatocellular Carcinoma following Transarterial Chemoembolization: Is It Helpful for Tumor Response?
por: Jiang, Tian'an, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q2g7gfnbgvsculd9e96vevvihs